Manhattan Associates Inc. diskutieren
Manhattan Associates Inc.
WKN: 913804 / Symbol: MANH / Name: Manhattan Assoc / Aktie / Software & Informationsdienstleistungen / Mid Cap /
150,00 €
-1,32 %
Manhattan Associates, Inc. (NASDAQ: MANH) had its price target lowered by analysts at Raymond James from $305.00 to $270.00. They now have an "outperform" rating on the stock.
Ratings data for MANH provided by MarketBeat
Manhattan Associates, Inc. (NASDAQ: MANH) had its price target lowered by analysts at DA Davidson from $315.00 to $270.00. They now have a "buy" rating on the stock.
Ratings data for MANH provided by MarketBeat
Manhattan Associates, Inc. (NASDAQ: MANH) had its price target lowered by analysts at Loop Capital from $310.00 to $275.00. They now have a "buy" rating on the stock.
Ratings data for MANH provided by MarketBeat
Manhattan Associates, Inc. (NASDAQ: MANH) had its price target lowered by analysts at Piper Sandler from $268.00 to $200.00. They now have an "overweight" rating on the stock.
Ratings data for MANH provided by MarketBeat
Manhattan Associates, Inc. (NASDAQ: MANH) had its price target lowered by analysts at Truist Financial Co. from $285.00 to $185.00. They now have a "buy" rating on the stock.
Ratings data for MANH provided by MarketBeat
Manhattan Associates, Inc. (NASDAQ: MANH) had its price target lowered by analysts at DA Davidson from $270.00 to $195.00. They now have a "buy" rating on the stock.
Ratings data for MANH provided by MarketBeat
Manhattan Associates, Inc. (NASDAQ: MANH) had its price target raised by analysts at DA Davidson from $195.00 to $200.00. They now have a "buy" rating on the stock.
Ratings data for MANH provided by MarketBeat
Manhattan Associates, Inc. (NASDAQ: MANH) had its price target raised by analysts at Truist Financial Co. from $180.00 to $190.00. They now have a "buy" rating on the stock.
Ratings data for MANH provided by MarketBeat
Manhattan Associates, Inc. (NASDAQ: MANH) had its price target raised by analysts at Robert W. Baird from $197.00 to $212.00. They now have an "outperform" rating on the stock.
Ratings data for MANH provided by MarketBeat
Manhattan Associates, Inc. (NASDAQ: MANH) had its price target raised by analysts at DA Davidson from $200.00 to $225.00. They now have a "buy" rating on the stock.
Ratings data for MANH provided by MarketBeat
Manhattan Associates, Inc. (NASDAQ: MANH) had its price target raised by analysts at Truist Financial Co. from $190.00 to $210.00. They now have a "buy" rating on the stock.
Ratings data for MANH provided by MarketBeat
Manhattan Associates, Inc. (NASDAQ: MANH) is now covered by analysts at Morgan Stanley. They set an "underweight" rating and a $190.00 price target on the stock.
Ratings data for MANH provided by MarketBeat
Manhattan Associates, Inc. (NASDAQ: MANH) had its price target raised by analysts at Robert W. Baird from $212.00 to $230.00. They now have an "outperform" rating on the stock.
Ratings data for MANH provided by MarketBeat
Manhattan Associates, Inc. (NASDAQ: MANH) had its price target raised by analysts at Truist Financial Corporation from $210.00 to $230.00. They now have a "buy" rating on the stock.
Ratings data for MANH provided by MarketBeat
Manhattan Associates, Inc. (NASDAQ: MANH) had its price target raised by analysts at DA Davidson from $225.00 to $250.00. They now have a "buy" rating on the stock.
Ratings data for MANH provided by MarketBeat
Manhattan Associates, Inc. (NASDAQ: MANH) had its price target raised by analysts at Raymond James Financial, Inc. from $195.00 to $250.00. They now have an "outperform" rating on the stock.
Ratings data for MANH provided by MarketBeat
Manhattan Associates (NASDAQ:MANH) had its price target lowered by analysts at Stifel Nicolaus from $250.00 to $240.00. They now have a "buy" rating on the stock.
Ratings data for MANH provided by MarketBeat
Manhattan Associates (NASDAQ:MANH) had its price target lowered by analysts at Barclays PLC from $244.00 to $239.00. They now have an "overweight" rating on the stock.
Ratings data for MANH provided by MarketBeat
Neueste Beiträge
Wells_Fargo___Compan in Johnson & Johnson diskutieren